loading

Theravance Biopharma Inc Aktie (TBPH) Neueste Nachrichten

pulisher
04:04 AM

What institutional flow reveals about Theravance Biopharma Inc.Trade Flow Monitor with Volume Tracker - Newser

04:04 AM
pulisher
03:48 AM

Using Ichimoku Cloud for Theravance Biopharma Inc. technicals7-Day Equity Return Range Forecast Model - Newser

03:48 AM
pulisher
Jul 28, 2025

How strong is Theravance Biopharma Inc. company’s balance sheetBest Dividend Report For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Theravance Biopharma Inc. in the next 12 monthsRapid market gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Theravance Biopharma to Report Second Quarter 2025 Financial Results on August 12, 2025 - Lelezard

Jul 28, 2025
pulisher
Jul 28, 2025

Theravance Biopharma Sets Q2 Earnings Date: Key Financial Results Coming August 12 After Market Close - Stock Titan

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional flow reveals about Theravance Biopharma Inc. 3-Day Market Movement Forecast Analysis - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Applying Wyckoff theory to Theravance Biopharma Inc. stock Free Reliable Investment Entry Point Signals - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Applying Wyckoff theory to Theravance Biopharma Inc. stock Investment Timeline and ROI Summary Report - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Theravance Biopharma Inc. as a “Buy”Achieve rapid returns with smart investment plans - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Theravance Biopharma Inc. stock overvalued or undervaluedInvest confidently with data-driven strategies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Theravance Biopharma Inc.Get expert analysis on top stock picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Theravance Biopharma Inc.Consistent high-performance stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Moving Average Trends for Theravance Biopharma Inc. Stock: What They IndicateHigh Accuracy Alerts - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Theravance Biopharma Inc. Stock Performance After Earnings: Historical InsightsHigh Potential Safe Trades - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Is Theravance Biopharma Inc. stock a good hedge against inflationFree Short-Term Stock Picks - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Theravance Biopharma Inc. stock price move sharplyMinimized Risk Trading Plan - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why Theravance Biopharma Inc. stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Theravance Biopharma Inc. Stock Analysis and ForecastOutstanding capital appreciation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Theravance Biopharma Inc. a good long term investmentFree Predictions - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Theravance Biopharma Inc. stockExtraordinary earning power - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 23, 2025

Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizen Tribune

Jul 23, 2025
pulisher
Jul 23, 2025

Exclusive: Theravance Biopharma Leadership Reveals Strategic Updates at BTIG Conference Next Week - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Theravance Biopharma Inc. stock priceConsistent triple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Theravance Biopharma Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 22, 2025
pulisher
Jul 17, 2025

Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics - The Globe and Mail

Jul 17, 2025
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):